A Pilot Study of Rapid HIV Treatment Initiation, Access and Engagement in Care (RHAE)
Phase of Trial: Phase II
Latest Information Update: 02 Dec 2019
Price : $35 *
At a glance
- Drugs Dolutegravir (Primary) ; Emtricitabine/tenofovir alafenamide (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms RHAE
- 26 Nov 2019 Planned End Date changed from 13 Nov 2020 to 13 May 2020.
- 26 Nov 2019 Planned primary completion date changed from 13 Nov 2019 to 13 May 2020.
- 07 May 2018 New trial record